Email Print this page Bookmark this page

Treatments for Dry Eye

Other Patient options

Dry Eye can adversely affect your patient’s quality of life, making once-routine activities difficult to do. However, personal habits and environmental conditions can play a role in Dry Eye. The following are a few options you might suggest to help improve your patient’s symptoms*:

  • Advise frequent pauses and increased blinking during prolonged activities such as reading, using the computer, or watching television. This can slow evaporation by rewetting the tear film and minimizing the amount of time that the ocular surface is exposed1-3
  • Encourage a diet that is higher in omega-3 fatty acids. The greater the level of omega-3 intake, the lower the risk for Dry Eye. Fish or omega-3 supplements are excellent sources for omega-3 fatty acids1,2
  • Suggest the use of a humidifier to add more moisture to the air, or an air cleaner to filter out the dust in the air. This may relieve Dry Eye symptoms, especially in climate-controlled public spaces, such as office buildings1,2

Click the following links to learn more about Dry Eye treatments:

Indications and Usage

LACRISERT® is indicated in patients with moderate to severe Dry Eye syndromes, including keratoconjunctivitis sicca. LACRISERT® is indicated especially in patients who remain symptomatic after an adequate trial of therapy with artificial tear solutions. LACRISERT® is also indicated for patients with exposure keratitis, decreased corneal sensitivity, and recurrent corneal erosions.

Important Safety Information

LACRISERT® is contraindicated in patients who are hypersensitive to hydroxypropyl cellulose. Instructions for inserting and removing LACRISERT® should be carefully followed. If improperly placed, LACRISERT® may result in corneal abrasion. Because LACRISERT® may cause transient blurred vision, patients should be instructed to exercise caution when driving or operating machinery. Patients should be cautioned against rubbing the eye(s) containing LACRISERT®.

The following adverse reactions have been reported, but were in most instances, mild and temporary: transient blurring of vision, ocular discomfort or irritation, matting or stickiness of eyelashes, photophobia, hypersensitivity, eyelid edema, and hyperemia.

*Results may vary. The more severe the case of Dry Eye, the less effective these options may be.

Reference: 1. The epidemiology of dry eye disease: report of the Epidemiology Subcommittee of the International Dry Eye Workshop (2007). Ocul Surf. 2007;5(2):93-107. Available at: http://www.tearfilm.org/dewsreport. Accessed January 5, 2009. 2. Management and therapy of dry eye disease: report of the Management and Therapy Subcommittee of the International Dry Eye Workshop (2007). Ocul Surf. 2007;5(2):163-178. Available at: http://www.tearfilm.org/dewsreport. Accessed January 5, 2009. 3. The definition and classification of dry eye disease: report of the Definition and Classification Subcommittee of the International Dry Eye Workshop (2007). Ocul Surf. 2007;5(2):75-92. Available at: http://www.tearfilm.org/dewsreport. Accessed January 5, 2009.

sample request using Lacrisert video patient tip sheet
©2012 Valeant Ophthalmics, a division of Valeant Pharmaceuticals North America LLC          Bridgewater, NJ 08807